作者单位：
University of Queensland Centre for Clinical Research, Faculty of Medicine,the University of Queensland, Herston, Queensland, Australia f.sime@uq.edu.au.
[1]
University of Queensland Centre for Clinical Research, Faculty of Medicine,the University of Queensland, Herston, Queensland, Australia.
[2]
Pharmacy Department, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, West Midlands, UK.
[3]
Pharmacy Department and OPAT Service, Nottingham University Hospitals, Nottingham, UK, Bristol, UK.
[4]
Department of Pharmacy/Infection, Imperial College Healthcare NHS Trust, London, UK.
[5]
Quality Assurance, University Hospitals Plymouth NHS Trust, Plymouth, UK and University Hospitals Bristol and Weston NHS Trust, Bristol, UK, Bristol, UK.
[6]
Queen Elizabeth University Hospital, Glasgow, Glasgow, UK.
[7]
British Society for Antimicrobial Chemotherapy, Birmingham, UK.
[8]
Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Queensland, Australia.
[9]
Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
[10]
Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.
[11]
DOI
10.1136/ejhpharm-2022-003286
PMID
35609967
发布时间
2024-03-02
换一批
换一批
